Evidence map›Paper›PMID 29632643›Full record

ArticleOncotarget2018

Analysis of the 9p21.3 sequence associated with coronary artery disease reveals a tendency for duplication in a CAD patient.

Natalay Kouprina, Mikhail Liskovykh, Nicholas C O Lee, Vladimir N Noskov, Joshua J Waterfall, Robert L Walker, Paul S Meltzer, Eric J Topol, Vladimir Larionov

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. TAR Cloning: Perspectives for Functional Genomics, Biomedicine, and Biotechnology.Molecular therapy. Methods & clinical development · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Natalay KouprinaDevelopmental Therapeutics Branch, National Cancer Institute, Bethesda, MD 20892, USA.
Mikhail Liskovykh *Developmental Therapeutics Branch, National Cancer Institute, Bethesda, MD 20892, USA.
Nicholas C O Lee *Developmental Therapeutics Branch, National Cancer Institute, Bethesda, MD 20892, USA.
Vladimir N NoskovDevelopmental Therapeutics Branch, National Cancer Institute, Bethesda, MD 20892, USA.
Joshua J WaterfallGenetics Branch, National Cancer Institute, Bethesda, MD 20892, USA.
Robert L WalkerGenetics Branch, National Cancer Institute, Bethesda, MD 20892, USA.
Paul S MeltzerGenetics Branch, National Cancer Institute, Bethesda, MD 20892, USA.
Eric J TopolThe Scripps Translational Science Institute, The Scripps Research Institute and Scripps Health, La Jolla, CA 92037, USA.
Vladimir LarionovDevelopmental Therapeutics Branch, National Cancer Institute, Bethesda, MD 20892, USA.
National Cancer Institute · USScripps Research Institute · US

Funding

Cancer Genomics Technology DevelopmentZIABC011091 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MELTZER, PAUL S. · 2009 to 2025
$16.9M
6 · The paper itself

Abstract

Tandem segmental duplications (SDs) greater than 10 kb are widespread in complex genomes. They provide material for gene divergence and evolutionary adaptation, while formation of specific

Indexed as

9p21CAD intervalgenome alterationssegmental duplicationTAR-cloning

Identifiers

PMID29632643
PMCPMC5880603
OpenAlexW2789516242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.